1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Dignitana AB (publ)
  6. News
  7. Summary
    DIGN   SE0002108001

DIGNITANA AB (PUBL)

(DIGN)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-06-30 am EDT
6.200 SEK   -4.62%
06/16Dignitana secures SEK 10 million line of credit from largest shareholder
AQ
06/16Dignitana AB Secures SEK 10 Million Line of Credit from Largest Shareholder
CI
06/16Dignitana announces American Medical Association reaffirms policy supporting scalp cooling
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dignitana : backed insurance legislation clears Texas House, progresses to Senate

04/16/2021 | 03:24pm EDT

Dignitana AB, world leader in scalp cooling innovation, announces today that HB1588, a Bill mandating insurance plan coverage for scalp cooling in Texas, was passed in the Texas House of Representatives on Friday. The Bill was introduced by Rep. Jeff Leach and 4 other legislators and now moves to the Texas Senate where it will be introduced by Sen. Angela Paxton as SB 862. Once passed in the Senate, the Bill then requires approval by Texas Governor Greg Abbott before being signed into law. If approved, it would take effect in September 2021.

Dignitana began working with Rep. Jeff Leach early in 2019 to initiate this legislation. In May 2019 a similar Bill was passed in the Texas House, but that legislative session ended before the Bill was brought to a vote. The Texas legislature only meets every other year.

"We were honored to work with Rep. Jeff Leach to get this legislation introduced and passed to provide cancer patients with coverage for scalp cooling," said William Cronin, CEO of Dignitana AB. "Removing financial barriers to scalp cooling is critical to our ability to help more patients, and we are happy to see the first steps being made in that direction right here in our home state of Texas."

For More Information Contact 

Melissa Bourestom, VP Corporate Communications,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.se or www.dignicap.com. 

https://news.cision.com/dignitana-ab/r/dignitana-backed-insurance-legislation-clears-texas-house--progresses-to-senate,c3327540

https://mb.cision.com/Main/2116/3327540/1402999.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about DIGNITANA AB (PUBL)
06/16Dignitana secures SEK 10 million line of credit from largest shareholder
AQ
06/16Dignitana AB Secures SEK 10 Million Line of Credit from Largest Shareholder
CI
06/16Dignitana announces American Medical Association reaffirms policy supporting scalp cool..
AQ
05/19Bulletin from the annual general meeting of Dignitana AB (publ)
AQ
05/19Dignitana AB Publishes Q1 2022 Interim Report
AQ
05/19Dignitana AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/17Dignitana Names New CFO
MT
05/17Dignitana AB appoints Chief Financial Officer
AQ
05/17Dignitana AB Appoints Ulf Jönsson as Chief Financial Officer
CI
04/28Dignitana AB publishes Annual Report for 2021
AQ
More news
Financials
Sales 2021 58,0 M 5,66 M 5,66 M
Net income 2021 -43,0 M -4,20 M -4,20 M
Net Debt 2021 4,00 M 0,39 M 0,39 M
P/E ratio 2021 -8,86x
Yield 2021 -
Capitalization 403 M 39,4 M 39,4 M
EV / Sales 2021 7,02x
EV / Sales 2022
Nbr of Employees 23
Free-Float 74,0%
Chart DIGNITANA AB (PUBL)
Duration : Period :
Dignitana AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 6,20
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Catarina Mard Lowenadler Chief Executive Officer
Alf Christensson Chief Financial Officer
Klas Rune Arildsson Chairman
Joseph Gilbert Coite Chief Operating Officer
Lina Karlsson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DIGNITANA AB (PUBL)-25.80%41
NOVOCURE LIMITED-3.57%7 572
MASIMO CORPORATION-53.18%7 555
SHOCKWAVE MEDICAL, INC.8.99%6 957
GETINGE AB-40.60%6 259
IRAY TECHNOLOGY COMPANY LIMITED-4.80%4 941